Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lorch

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
The New England Journal of Medicine|October 9, 2014
Response and acquired resistance to everolimus in anaplastic thyroid cancerNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
Science Advances|January 21, 2022
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemiaCuijuan Han, Alireza Khodadadi-Jamayran, Adam H Lorch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid CancerWilliam J Gibson, Daniel T Ruan, Vera A Paulson, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2020
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic CarcinomaUmair Mahmood, Andrew Bang, Yu-Hui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and NeckGlenn J Hanna, Anne O'Neill, Kee-Young Shin, et al.
Cancer Discovery|May 24, 2020
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in LeukemiaYalu Zhou, Cuijuan Han, Eric Wang, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Cancer Discovery|November 5, 2017
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W Jenkins, Amir R Aref, Patrick H Lizotte, et al.
ACS Nano|September 4, 2025
33 Unresolved Questions in Nanoscience and NanotechnologyChad A Mirkin, Sarah Hurst Petrosko, Natalie Artzi, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
The New England Journal of Medicine|October 9, 2014
Response and acquired resistance to everolimus in anaplastic thyroid cancerNikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, et al.
JAMA Oncology|July 31, 2015
Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal CarcinomaEleni M Rettig, Alicia Wentz, Marshall R Posner, et al.
Science Advances|January 21, 2022
SF3B1 homeostasis is critical for survival and therapeutic response in T cell leukemiaCuijuan Han, Alireza Khodadadi-Jamayran, Adam H Lorch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid CancerWilliam J Gibson, Daniel T Ruan, Vera A Paulson, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2020
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic CarcinomaUmair Mahmood, Andrew Bang, Yu-Hui Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and NeckGlenn J Hanna, Anne O'Neill, Kee-Young Shin, et al.
Cancer Discovery|May 24, 2020
Posttranslational Regulation of the Exon Skipping Machinery Controls Aberrant Splicing in LeukemiaYalu Zhou, Cuijuan Han, Eric Wang, et al.
Cancer Discovery|November 5, 2017
CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell ActivationJiehui Deng, Eric S Wang, Russell W Jenkins, et al.
Cancer Discovery|November 5, 2017
<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor SpheroidsRussell W Jenkins, Amir R Aref, Patrick H Lizotte, et al.
ACS Nano|September 4, 2025
33 Unresolved Questions in Nanoscience and NanotechnologyChad A Mirkin, Sarah Hurst Petrosko, Natalie Artzi, et al.
Pageof 9